Cargando…
MTHFR and VDR Polymorphisms Improve the Prognostic Value of MYCN Status on Overall Survival in Neuroblastoma Patients
Single nucleotide polymorphisms (SNPs) in Pharmacogenetics can play an important role in the outcomes of the chemotherapy treatment in Neuroblastoma, helping doctors maximize efficacy and minimize toxicity. Employing AgenaBioscience MassArray, 96 SNPs were genotyped in 95 patients looking for associ...
Autores principales: | Olivera, Gladys G., Yáñez, Yania, Gargallo, Pablo, Sendra, Luis, Aliño, Salvador F., Segura, Vanessa, Sanz, Miguel Ángel, Cañete, Adela, Castel, Victoria, Font De Mora, Jaime, Hervás, David, Berlanga, Pablo, Herrero, María José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215604/ https://www.ncbi.nlm.nih.gov/pubmed/32295184 http://dx.doi.org/10.3390/ijms21082714 |
Ejemplares similares
-
Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?
por: Olivera, Gladys G., et al.
Publicado: (2021) -
Pharmacogenetics implementation in the clinics: information and guidelines for germline variants
por: Olivera, Gladys, et al.
Publicado: (2019) -
Next-Generation Sequencing Identifies Potential Actionable Targets in Paediatric Sarcomas
por: Juan Ribelles, Antonio, et al.
Publicado: (2021) -
Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy
por: Urtasun, Andrea, et al.
Publicado: (2023) -
Clinical Features of Neuroblastoma With 11q Deletion: An Increase in Relapse Probabilities In Localized And 4S Stages
por: J Ribelles, Antonio, et al.
Publicado: (2019)